Today news
About the same in other media
SoftBank-backed Neumora bags $2.51 billion valuation in lackluster debut
Reading now: 572
Neumora Therapeutics, which is backed by Amgen and Japan's SoftBank, fell in their market debut on Friday, giving the company a market capitalization of $2.51 billion.
The Watertown, Massachusetts-based company's shares debuted at $16.50 per share on Nasdaq, below the offer price of $17 apiece.
The ongoing surge in listings points to a nascent recovery in the U.S. IPO market amid growing expectations of a pause in interest rate hikes by the Federal Reserve.
Neumora, which is developing drugs for brain diseases, raised $250 million by selling 14.7 million shares priced at the mid-point of its previously disclosed range.
About this in other media
Toshiba says $14 billion takeover bid by JIP has succeeded investing.com /1 year ago
Toshiba to go private after winning shareholder support for JIP's $14 billion takeover offer economictimes.indiatimes.com /1 year ago
JIP buys 78.65% share of Toshiba through tender offer, close to complete $14 billion takeover livemint.com /1 year ago
Show more
The website fvbb.com is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.
